# Brown Biotech AI Drug Discovery Platform
## Integration: AlphaFold 3 + De Novo RL + XAI

**Date:** 2026-04-25  
**Purpose:** AI-powered drug discovery for refractory cancer  
**Integrations:** AlphaFold 3, De Novo RL, Explainable AI  

---

## Executive Summary

| Component | Technology | Status | Integration |
|-----------|------------|--------|-------------|
| **Protein Structure** | AlphaFold 3 | ✅ Available | `alphafold3_integration.py` |
| **De Novo Design** | RL-based generation | ✅ Available | `mrl_integration.py` |
| **XAI** | Gradient-based attribution | 🔄 In Progress | `xai_integration.py` |
| **Virtual Screening** | Structure-based docking | 🔄 Planned | `docking_integration.py` |

---

## 1. AlphaFold 3 Integration

### What It Does

```
AlphaFold 3 capabilities:
├── Protein structure prediction (single chain)
├── Complex prediction (protein-protein)
├── Protein-ligand complexes (NEW in v3)
├── Protein-nucleic acid complexes
└── Updated training data (2024)
```

### Usage

```python
from integration.alphafold3_integration import AlphaFoldResearcher

af = AlphaFoldResearcher()

# Predict DGAT1 structure
structure = af.predict_structure("DGAT1_sequence")

# Predict DGAT1-ligand complex
complex = af.predict_complex(
    protein="DGAT1",
    ligand="DGAT1_inhibitor_smiles"
)

# Get binding site residues
binding_site = af.get_binding_site(structure)
```

### Application to Our Targets

| Target | Use Case | Priority |
|--------|----------|----------|
| **DGAT1** | Binding site identification, inhibitor design | ⭐⭐⭐⭐⭐ |
| **CD36** | Antibody epitope mapping | ⭐⭐⭐⭐ |
| **ATGL** | Activator binding site | ⭐⭐⭐ |
| **ACSL4** | Substrate binding analysis | ⭐⭐⭐ |

---

## 2. De Novo RL Integration (Existing)

### Current Status

```python
from integration.mrl_integration import MRLDrugDesigner

designer = MRLDrugDesigner()

# Generate leads for DGAT1
leads = designer.generate_leads(
    target="DGAT1",
    num_molecules=100,
    properties=["binding_affinity", "synthesizability"]
)
```

### Enhancement: Add RL with Synthesizability

```python
# SyntheMol-RL style enhancement
from integration.de_novo_rl import SynthMolRL

rl_designer = SynthMolRL(
    target="DGAT1",
    objectives=[
        "binding_affinity",     # Maximize
        "synthesizability",     # Maximize  
        "ADMET",               # Satisfy
        "Lilly_rules"          # Satisfy
    ],
    rl_algorithm="PPO"         # Proximal Policy Optimization
)
```

---

## 3. Explainable AI (XAI) Integration

### Why XAI Matters

```
┌─────────────────────────────────────────────────────────────┐
│                    XAI BENEFITS                               │
├─────────────────────────────────────────────────────────────┤
│                                                              │
│  1. MECHANISM UNDERSTANDING                                 │
│     "Why does this molecule bind to DGAT1?"                  │
│     → Visualize key interactions (H-bond, hydrophobic)        │
│                                                              │
│  2. DECISION SUPPORT                                        │
│     "Which compound should we synthesize first?"              │
│     → AI confidence + explanation                           │
│                                                              │
│  3. REGULATORY APPROVAL                                     │
│     "How do we know the AI is right?"                        │
│     → Transparent, auditable predictions                     │
│                                                              │
│  4. DEBUGGING                                               │
│     "Why did this prediction fail?"                          │
│     → Identify model weaknesses                              │
│                                                              │
└─────────────────────────────────────────────────────────────┘
```

### XAI Methods for Drug Discovery

| Method | Use Case | Implementation |
|--------|----------|---------------|
| **Grad-CAM** | Visualize binding site importance | ✅ Planned |
| **SHAP** | Feature attribution for molecules | ✅ Planned |
| **Attention Maps** | Transformer-based analysis | 🔄 Future |
| **Counterfactual** | "What if" scenarios | 🔄 Future |

### Usage

```python
from integration.xai_integration import DrugDiscoveryXAI

xai = DrugDiscoveryXAI(model=our_model)

# Explain why compound X binds to DGAT1
explanation = xai.explain(
    compound=compound_smiles,
    target="DGAT1",
    method="grad_cam"
)

# Get key residues
key_residues = explanation.get("important_residues")
print(f"Key binding residues: {key_residues}")
```

---

## 4. Integrated Platform Architecture

```
┌─────────────────────────────────────────────────────────────┐
│          BROWN BIOTECH AI DRUG DISCOVERY PLATFORM               │
├─────────────────────────────────────────────────────────────┤
│                                                              │
│  ┌─────────────┐     ┌─────────────┐     ┌─────────────┐  │
│  │  AlphaFold │     │  De Novo   │     │     XAI    │  │
│  │      3     │────▶│    RL      │────▶│  Analysis   │  │
│  └─────────────┘     └─────────────┘     └─────────────┘  │
│        │                   │                   │            │
│        ▼                   ▼                   ▼            │
│  ┌─────────────────────────────────────────────────────┐  │
│  │              TARGET PRIORITIZATION (ARP v24)            │  │
│  └─────────────────────────────────────────────────────┘  │
│        │                   │                   │            │
│        ▼                   ▼                   ▼            │
│  ┌─────────────┐     ┌─────────────┐     ┌─────────────┐  │
│  │  Structure  │     │   Lead     │     │  Mechanism │  │
│  │  Analysis   │     │ Generation │     │  Explain   │  │
│  └─────────────┘     └─────────────┘     └─────────────┘  │
│                                                              │
└─────────────────────────────────────────────────────────────┘
```

---

## 5. Target Application: DGAT1 siRNA Delivery

### Workflow

```
1. TARGET IDENTIFICATION
   └── ARP v24: DGAT1 validated as lung cancer target

2. STRUCTURE PREDICTION (AlphaFold 3)
   └── DGAT1 binding site identification
   └── siRNA binding interface analysis

3. DE NOVO DESIGN (RL)
   └── DGAT1-targeted siRNA sequences
   └── Lipid nanoparticle optimization
   └── Lung-targeting ligand design

4. XAI VALIDATION
   └── Why this siRNA targets DGAT1?
   └── Delivery mechanism explanation
   └── Toxicity prediction
```

### Code Example

```python
from integration.alphafold3_integration import AlphaFoldResearcher
from integration.de_novo_rl import SynthMolRL
from integration.xai_integration import DrugDiscoveryXAI

# Step 1: Structure
af = AlphaFoldResearcher()
dgat1_structure = af.predict_structure(dgat1_sequence)

# Step 2: Generate delivery candidates
rl = SynthMolRL(target="DGAT1", objectives=["delivery", "stability"])
candidates = rl.generate(num_molecules=50)

# Step 3: Explain
xai = DrugDiscoveryXAI()
for candidate in candidates[:10]:
    explanation = xai.explain(candidate, "DGAT1")
    print(f"{candidate}: {explanation['confidence']:.2f}")
```

---

## 6. Installation & Dependencies

### Required Packages

```bash
# Core AI
pip install torch>=2.0
pip install transformers>=4.30
pip install pyTorch-lightning

# AlphaFold (ColabFold for local)
pip install colabfold

# XAI
pip install captum  # For GradCAM, SHAP
pip install shap

# Molecule handling
pip install rdkit-pypi
pip install py3dmol

# Optional: Docking
pip install autodock-vina
```

### Test Installation

```bash
cd ~/.openclaw/workspace/arp-v24
python -c "
from integration.alphafold3_integration import AlphaFoldResearcher
from integration.mrl_integration import MRLDrugDesigner
from integration.xai_integration import DrugDiscoveryXAI
print('All integrations: OK')
"
```

---

## 7. Development Roadmap

### Phase 1: Core Integration (1-2 months)

| Task | Status | Owner |
|------|--------|-------|
| AlphaFold 3 integration | ✅ | System |
| De Novo RL enhancement | 🔄 | System |
| Basic XAI (Grad-CAM) | 🔄 | System |

### Phase 2: Platform Building (2-3 months)

| Task | Status | Owner |
|------|--------|-------|
| Web UI for predictions | 📋 | TBD |
| Database for compounds | 📋 | TBD |
| API for external access | 📋 | TBD |

### Phase 3: Advanced Features (3-6 months)

| Feature | Description |
|---------|-------------|
| **Multi-target optimization** | Simultaneous CD36 + DGAT1 |
| **Active learning** | RL with experimental feedback |
| **Generative chemistry** | Full molecule generation |

---

## 8. Quick Start Guide

### 1. Predict DGAT1 Structure

```python
from integration.alphafold3_integration import AlphaFoldResearcher

af = AlphaFoldResearcher()
structure = af.predict_structure("MVWPNPLLLLLAGV...")
print(f"pLDDT: {structure['plddt']:.1f}")
```

### 2. Generate De Novo Leads

```python
from integration.mrl_integration import MRLDrugDesigner

designer = MRLDrugDesigner()
leads = designer.generate_leads(target="DGAT1", num_molecules=10)
for lead in leads:
    print(f"{lead['smiles']} - Score: {lead['score']:.3f}")
```

### 3. Explain Prediction

```python
from integration.xai_integration import DrugDiscoveryXAI

xai = DrugDiscoveryXAI()
exp = xai.explain(
    compound="CC(=O)Nc1ccc(cc1)C(=O)NCCN",
    target="DGAT1"
)
print(f"Important residues: {exp['key_residues']}")
```

---

## 9. File Structure

```
integration/
├── alphafold3_integration.py      # AlphaFold 3 wrapper
├── mrl_integration.py             # De Novo RL (existing)
├── xai_integration.py             # Explainable AI
├── docking_integration.py          # Virtual docking (planned)
└── README_ai_platform.md          # This file
```

---

## 10. References

1. Abramson et al. (2024). AlphaFold 3. Nature
2. Sampa et al. (2026). Reinforcement Learning in De Novo Drug Design. Health Sci Rep
3. Lundberg et al. (2020). SHAP. Nature Methods
4. Spring et al. (2025). SyntheMol-RL. ACS Cent Sci

---

*Generated by ARP v24 Research Team · 2026-04-25*  
*For: Brown Biotech AI Drug Discovery Platform*